Dr. Erica Parrotta, D.O
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $90,462 | 2 | 81.0% |
| Consulting Fee | $10,880 | 7 | 9.7% |
| Food and Beverage | $6,401 | 259 | 5.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,025 | 1 | 1.8% |
| Travel and Lodging | $1,744 | 5 | 1.6% |
| Education | $210.20 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $90,677 | 11 | $0 (2023) |
| Genentech USA, Inc. | $7,006 | 17 | $0 (2024) |
| Celgene Corporation | $4,784 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,399 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,174 | 4 | $0 (2024) |
| ABBVIE INC. | $2,158 | 120 | $0 (2024) |
| EMD Serono, Inc. | $646.17 | 12 | $0 (2024) |
| Acorda Therapeutics, Inc | $461.83 | 1 | $0 (2017) |
| GENZYME CORPORATION | $293.85 | 7 | $0 (2023) |
| Amgen Inc. | $283.37 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,213 | 53 | Celgene Corporation ($4,005) |
| 2023 | $1,387 | 54 | ABBVIE INC. ($627.53) |
| 2022 | $10,450 | 93 | Genentech USA, Inc. ($6,881) |
| 2021 | $1,284 | 64 | Novartis Pharmaceuticals Corporation ($263.20) |
| 2020 | $249.12 | 6 | EMD Serono, Inc. ($168.61) |
| 2019 | $90,348 | 4 | Biogen, Inc. ($90,000) |
| 2017 | $791.11 | 4 | Acorda Therapeutics, Inc ($461.83) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $148.69 | General |
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $777.64 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Travel and Lodging | Cash or cash equivalent | $212.19 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $50.12 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $50.12 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $31.39 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 100 | 123 | $37,363 | $13,416 |
| 2022 | 3 | 151 | 196 | $66,076 | $26,840 |
| 2021 | 2 | 64 | 86 | $27,458 | $12,220 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 89 | $29,135 | $10,310 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 34 | $8,228 | $3,106 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 123 | $37,497 | $16,396 | 43.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 58 | 58 | $25,387 | $8,974 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 15 | $3,192 | $1,470 | 46.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 38 | 60 | $16,980 | $8,206 | 48.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $10,478 | $4,013 | 38.3% |
About Dr. Erica Parrotta, D.O
Dr. Erica Parrotta, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1275927303.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erica Parrotta, D.O has received a total of $111,723 in payments from pharmaceutical and medical device companies, with $7,213 received in 2024. These payments were reported across 278 transactions from 28 companies. The most common payment nature is "Grant" ($90,462).
As a Medicare-enrolled provider, Parrotta has provided services to 315 Medicare beneficiaries, totaling 405 services with total Medicare billing of $52,476. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Albany, NY
- Active Since 03/26/2015
- Last Updated 06/04/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1275927303
Products in Payments
- OCREVUS (Biological) $6,901
- ZEPOSIA (Drug) $6,640
- KESIMPTA (Drug) $2,374
- QULIPTA (Drug) $1,281
- UBRELVY (Drug) $811.96
- AMPYRA (Drug) $461.83
- TYSABRI (Biological) $444.31
- Mavenclad (Drug) $261.54
- AUBAGIO (Drug) $183.77
- Aimovig (Biological) $158.37
- VYEPTI (Biological) $155.03
- ZINBRYTA (Biological) $121.36
- AUSTEDO (Drug) $114.90
- Ponvory (Drug) $96.69
- DISEASE STATE (Drug) $91.08
- BOTOX (Biological) $65.05
- WAKIX (Drug) $36.72
- Ocrevus (Biological) $35.20
- NURTEC ODT (Drug) $34.72
- AJOVY (Biological) $33.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736
Khoa Ngo, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $13,532